Hinestrosa, Juan Pablo http://orcid.org/0000-0002-8348-0403
Sears, Rosalie C. http://orcid.org/0000-0003-1558-2413
Dhani, Harmeet
Lewis, Jean M. http://orcid.org/0000-0001-6978-5166
Schroeder, Gregor http://orcid.org/0000-0002-9723-7789
Balcer, Heath I.
Keith, Dove http://orcid.org/0000-0001-6104-3264
Sheppard, Brett C.
Kurzrock, Razelle http://orcid.org/0000-0003-4110-1214
Billings, Paul R. http://orcid.org/0000-0003-1198-0537
Funding for this research was provided by:
Biological Dynamics
Article History
Received: 14 April 2023
Accepted: 24 August 2023
First Online: 19 October 2023
Competing interests
: J.P.H., H.D., J.M.L., H.I.B., and P.R.B. are current employees of Biological Dynamics. G.S. is a former employee of Biological Dynamics. J.P.H. is a named inventor in patents held by Biological Dynamics. R.C.S. received support from NCI R01 CA186241, U01 CA224012, U01 CA278923; Department of Defense PA210068; and the Brenden-Colson Center Foundation, and is a consultant for Larkspur Biosciences, a member of the scientific advisory board of RAPPTA Therapeutics and has received sponsored research support from Cardiff Oncology, AstraZeneca Partner of Choice grant award. R.K. is s funded in part by 5U01CA180888-08 and 5UG1CA233198-05. R.K. has received research funding from Boehringer Ingelheim, Debiopharm, Foundation Medicine, Genentech, Grifols, Guardant, Incyte, Konica Minolta, Medimmune, Merck Serono, Omniseq, Pfizer, Sequenom, Takeda, and TopAlliance and from the NCI; as well as consultant and/or speaker fees and/or advisory board/consultant for Actuate Therapeutics, AstraZeneca, Bicara Therapeutics, Inc., Biological Dynamics, Caris, Datar Cancer Genetics, Daiichi, EISAI, EOM Pharmaceuticals, Iylon, LabCorp, Merck, NeoGenomics, Neomed, Pfizer, Prosperdtx, Regeneron, Roche, TD2/Volastra, Turning Point Therapeutics, X-Biotech; has an equity interest in CureMatch Inc. and IDbyDNA; serves on the Board of CureMatch and CureMetrix, and is a co-founder of CureMatch. B.C.S. received support from NCI U01 CA278923 and the Brenden-Colson Center Foundation. D.K. declares no competing interests.